| 000 | 01829 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515073732.0 | ||
| 264 | 0 | _c20071126 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0885-3924 | ||
| 024 | 7 |
_a10.1016/j.jpainsymman.2006.12.014 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarcellin, Fabienne | |
| 245 | 0 | 0 |
_aAdding HCV treatment to HIV treatment in HIV-HCV coinfected patients: the impact on the different dimensions of fatigue and self-reported side effects. _h[electronic resource] |
| 260 |
_bJournal of pain and symptom management _cOct 2007 |
||
| 300 |
_a413-21 p. _bdigital |
||
| 500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepression _xepidemiology |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFatigue _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFrance _xepidemiology |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSelf-Examination |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 700 | 1 | _aPréau, Marie | |
| 700 | 1 | _aDellamonica, Pierre | |
| 700 | 1 | _aRavaux, Isabelle | |
| 700 | 1 | _aKurkdji, Patrick | |
| 700 | 1 | _aProtopopescu, Camelia | |
| 700 | 1 | _aCarrieri, Maria Patrizia | |
| 700 | 1 | _aSpire, Bruno | |
| 773 | 0 |
_tJournal of pain and symptom management _gvol. 34 _gno. 4 _gp. 413-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpainsymman.2006.12.014 _zAvailable from publisher's website |
| 999 |
_c17152030 _d17152030 |
||